Correlation Between Injective and TRON

Can any of the company-specific risk be diversified away by investing in both Injective and TRON at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Injective and TRON into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Injective and TRON, you can compare the effects of market volatilities on Injective and TRON and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Injective with a short position of TRON. Check out your portfolio center. Please also check ongoing floating volatility patterns of Injective and TRON.

Diversification Opportunities for Injective and TRON

0.68

Correlation Coefficient

Injective  TRON

Poor diversification

The 3 months correlation between Injective and TRON is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Injective and TRON in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TRON and Injective is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Injective are associated (or correlated) with TRON. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TRON has no effect on the direction of Injective i.e., Injective and TRON go up and down completely randomly.

Pair Corralation between Injective and TRON

Assuming the 90 days trading horizon Injective is expected to under-perform the TRON. In addition to that, Injective is 1.88 times more volatile than TRON. It trades about -0.15 of its total potential returns per unit of risk. TRON is currently generating about -0.02 per unit of volatility. If you would invest  25.00  in TRON on December 30, 2024 and sell it today you would lose (2.00) from holding TRON or give up 8.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Injective  vs.  TRON

Injective

Risk-Adjusted Performance

Very Weak

Over the last 90 days Injective has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Crypto's forward-looking indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for Injective shareholders.

TRON

Risk-Adjusted Performance

Very Weak

Over the last 90 days TRON has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, TRON is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Injective and TRON

The main advantage of trading using opposite Injective and TRON positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Injective position performs unexpectedly, TRON can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRON will offset losses from the drop in TRON's long position.

The idea behind Injective and TRON pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.